Increased plasma concentrations of acyl-coenzyme A binding protein (ACBP) predict future lung cancer development in smokers at risk of cardiovascular disease

These findings independently validate ACBP/DBI as a circulating biomarker of future LC development in at-risk individuals. Clinically, ACBP/DBI quantification could refine risk-adapted lung cancer screening strategies, guiding the frequency of low-dose CT scans and identifying candidates for preventive interventions, including potential ACBP/DBI-neutralizing therapies.

Authors

Institutions

Publication Details

Journal
Molecular Cancer
Published
2025-11-25
DOI
https://doi.org/10.1186/s12943-025-02507-3
Citations
1
Primary Topic
Peroxisome Proliferator-Activated Receptors
Type
article
Field-Weighted Citation Impact
0.81

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Increased plasma concentrations of acyl-coenzyme A binding protein (ACBP) predict future lung cancer development in smokers at risk of cardiovascular disease

Marine Fidelle, Magalie Martineau, David Boulate, Hui Chen et al.
1 citations
Molecular Cancer
Peroxisome Proliferator-Activated Receptors
0.81
article

Increased plasma concentrations of acyl-coenzyme A binding protein (ACBP) predict future lung cancer development in smokers at risk of cardiovascular disease

Marine Fidelle, Magalie Martineau, David Boulate, Hui Chen, Pamela Abdayem, Kuznetsova Tv, Laurence Zitvogel, Léa Montégut, Harry J. de Koning, Carlijn M. van der Aalst
article en
1 citations

Abstract

These findings independently validate ACBP/DBI as a circulating biomarker of future LC development in at-risk individuals. Clinically, ACBP/DBI quantification could refine risk-adapted lung cancer screening strategies, guiding the frequency of low-dose CT scans and identifying candidates for preventive interventions, including potential ACBP/DBI-neutralizing therapies.

Molecular CancerVol. 24(1)
Centre National de la Recherche Scientifique (FR), Inserm (FR), Université Paris Cité (FR), Aix-Marseille Université (FR), Université Paris-Saclay (FR), Institut Gustave Roussy (FR), Sorbonne Université (FR), Sorbonne Paris Cité (FR), Centre de Recherche des Cordeliers (FR), La Ligue Contre le Cancer (FR), Assistance Publique – Hôpitaux de Paris (FR), Hôpital Européen (FR), Hôpital Nord (FR), Hôpital Marie Lannelongue (FR), Erasmus University Rotterdam (NL), KU Leuven (BE)
European Commission, Agence Nationale de la Recherche, Ligue Contre le Cancer, China Scholarship Council, Université de Paris, HORIZON EUROPE Framework Programme
Openalex Percentile: Top 21%
Peroxisome Proliferator-Activated Receptors
0.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.